{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T02:05:29Z","timestamp":1776132329797,"version":"3.50.1"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jsm.jsexmed.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The subsequent health risks associated with Peyronie\u2019s disease (PD) are unknown.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>This cohort study assesses the risk of developing auto-immune conditions and common chronic health conditions after a diagnosis of PD. We hypothesize that an increase in auto-immune disease will be evident in men with PD, as has been suggested in smaller studies.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We determined the longitudinal incidence of 13 auto-immune diseases and 25 common chronic conditions in a cohort from the Truven Health Analytics (Ann Arbor, Michigan, USA) database from 2007\u20132013. The cohort included men with 1 of 3 exposures in 2007: (1) men with PD, (2) men with erectile dysfunction (ED) but not PD, and (3) men without PD or ED, matched on age and follow-up duration.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Outcomes<\/jats:title>\n                  <jats:p>To assess incidence, we utilized a Cox regression model adjusting for age, smoking, obesity, health care visits per year, urology visits per year, and years of follow-up.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We included 8,728 men with PD; 204,147 men with ED; and 87,280 controls. Men with PD had an increased risk of developing benign prostatic hyperplasia (hazard ratio [HR] 1.21, 95% CI 1.16\u20131.27), prostatitis (HR 1.21, 95% CI 1.12\u20131.31), and lower urinary tract symptoms (HR 1.10, 95% CI 1.05\u20131.16) when compared to both men with ED and age-matched controls without ED or PD even when controlling for the number of urology visits per year. Compared to controls, men with PD also had an increased risk of developing keloids. No significant risk for any auto-immune disease was observed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Clinical Implications<\/jats:title>\n                  <jats:p>Clinicians should have heightened awareness for these relevant co-morbidities when treating men with PD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Strengths &amp; Limitations<\/jats:title>\n                  <jats:p>Utilizing a claims database provides one of the largest cohorts of men with PD ever published but claims databases lack some individual patient data such as risk factors and demographic information relevant to PD, including: penile injury, history of urologic procedures, and other lifestyle factors.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Men with PD had a higher risk of benign prostatic hyperplasia, lower urinary tract symptoms, prostatitis, and keloids after a diagnosis of PD, but no increased risk of auto-immune conditions. These findings suggest a common etiology for these conditions that may manifest itself in diseases at different times in men\u2019s life cycle.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1016\/j.jsxm.2018.04.640","type":"journal-article","created":{"date-parts":[[2018,5,24]],"date-time":"2018-05-24T02:17:47Z","timestamp":1527128267000},"page":"894-901","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Increased Risk of Incident Disease in Men with Peyronie\u2019s Disease: Analysis of U.S. Claims Data"],"prefix":"10.1093","volume":"15","author":[{"given":"Alexander W.","family":"Pastuszak","sequence":"first","affiliation":[{"name":"Scott Department of Urology , Houston, TX , USA"},{"name":"Baylor College of Medicine , Houston, TX , USA"},{"name":"Center for Reproductive Medicine , Houston, TX , USA"},{"name":"Baylor College of Medicine , Houston, TX , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine M.","family":"Rodriguez","sequence":"additional","affiliation":[{"name":"Baylor College of Medicine , Houston, TX , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zachary J.","family":"Solomon","sequence":"additional","affiliation":[{"name":"Baylor College of Medicine , Houston, TX , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taylor P.","family":"Kohn","sequence":"additional","affiliation":[{"name":"Baylor College of Medicine , Houston, TX , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larry I.","family":"Lipshultz","sequence":"additional","affiliation":[{"name":"Scott Department of Urology , Houston, TX , USA"},{"name":"Baylor College of Medicine , Houston, TX , USA"},{"name":"Center for Reproductive Medicine , Houston, TX , USA"},{"name":"Baylor College of Medicine , Houston, TX , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael L.","family":"Eisenberg","sequence":"additional","affiliation":[{"name":"Departments of Urology and Obstetrics\/Gynecology , Stanford, CA , USA"},{"name":"Stanford University School of Medicine , Stanford, CA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,6,1]]},"reference":[{"key":"2023012309264700600_bib1","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/sj.ijir.3900877","article-title":"Clinical presentations of Peyronie's disease","volume":"14","author":"Pryor","year":"2002","journal-title":"Int J Impot Res"},{"key":"2023012309264700600_bib2","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/sj.ijir.3900863","article-title":"Epidemiology of Peyronie's disease","volume":"14","author":"Sommer","year":"2002","journal-title":"Int J Impot Res"},{"key":"2023012309264700600_bib3","first-page":"1007","article-title":"The incidence of Peyronie's disease in Rochester, Minnesota, 1950 through 1984","volume":"146","author":"Lindsay","year":"1991","journal-title":"J\u00a0Urol"},{"key":"2023012309264700600_bib4","first-page":"302","article-title":"Peyronie's disease in teenagers","volume":"9","author":"Tal","year":"2012","journal-title":"J\u00a0Sex Med"},{"key":"2023012309264700600_bib5","first-page":"27","article-title":"Peyronie disease in younger men: characteristics and treatment results","volume":"24","author":"Levine","year":"2003","journal-title":"J\u00a0Androl"},{"key":"2023012309264700600_bib6","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1046\/j.1464-4096.2001.02436.x","article-title":"The prevalence of Peyronie's disease: results of a large survey","volume":"88","author":"Schwarzer","year":"2001","journal-title":"BJU Int"},{"key":"2023012309264700600_bib7","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1023\/A:1014485204205","article-title":"Peyronie's disease: epidemiology and clinical presentation of 134 cases","volume":"32","author":"Perimenis","year":"2001","journal-title":"Int Urol Nephrol"},{"key":"2023012309264700600_bib8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jbspin.2011.05.027","article-title":"Genetics of Dupuytren's disease","volume":"79","author":"Michou","year":"2012","journal-title":"Joint Bone Spine"},{"key":"2023012309264700600_bib9","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/j.jhsa.2012.07.017","article-title":"Dupuytren diathesis and genetic risk","volume":"37","author":"Dolmans","year":"2012","journal-title":"J\u00a0Hand Surg"},{"key":"2023012309264700600_bib10","doi-asserted-by":"crossref","first-page":"5241","DOI":"10.1007\/s11552-009-9255-y","article-title":"Role of the HLA system in the pathogenesis of Dupuytren's disease","volume":"5","author":"McCarty","year":"2010","journal-title":"Hand (N Y)"},{"key":"2023012309264700600_bib11","first-page":"1529","article-title":"A\u00a0cross-sectional study for the analysis of clinical, sexual and laboratory conditions associated to Peyronie's disease","volume":"7","author":"Rhoden","year":"2010","journal-title":"J\u00a0Sex Med"},{"key":"2023012309264700600_bib12","first-page":"1062","article-title":"Peyronie's disease and autoimmunity\u2014a real-life clinical study and comprehensive review","volume":"12","author":"Ventimiglia","year":"2015","journal-title":"J\u00a0Sex Med"},{"key":"2023012309264700600_bib13","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1302\/0301-620X.45B4.709","article-title":"The genetic factor in Dupuytren's disease","volume":"45","author":"Ling","year":"1963","journal-title":"J\u00a0Bone Joint Surg Br"},{"key":"2023012309264700600_bib14","first-page":"291","article-title":"The genetic and bacteriological aspects of Peyronie's disease","volume":"157","author":"Ralph","year":"1997","journal-title":"J\u00a0Urol"},{"key":"2023012309264700600_bib15","first-page":"48","article-title":"Identification of an inherited form of Peyronie's disease with autosomal dominant inheritance and association with Dupuytren's contracture and histocompatibility B7 cross-reacting antigens","volume":"128","author":"Nyberg","year":"1982","journal-title":"J\u00a0Urol"},{"key":"2023012309264700600_bib16","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/ijir.2011.18","article-title":"The association between Peyronie's and Dupuytren's disease","volume":"23","author":"Nugteren","year":"2011","journal-title":"Int J Impot Res"},{"key":"2023012309264700600_bib17","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0090-4295(97)00333-6","article-title":"Immunologic findings in Peyronie's disease: a controlled study","volume":"50","author":"Schiavino","year":"1997","journal-title":"Urology"},{"key":"2023012309264700600_bib18","article-title":"Center for Behavioral Health Statistics and Quality Key substance use and mental health indicators in the United States: results from the 2015 national survey on drug use and health. HHS Publication No. SMA 16\u20134984, NSDUH Series H-51; 2016","year":"2016"},{"key":"2023012309264700600_bib19","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.diff.2011.05.007","article-title":"The functional role of reactive stroma in benign prostatic hyperplasia","volume":"82","author":"Schauer","year":"2011","journal-title":"Differentiation"},{"key":"2023012309264700600_bib20","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/pros.22668","article-title":"Upregulation of androgen-responsive genes and transforming growth factor-beta1 cascade genes in a rat model of non-bacterial prostatic inflammation","volume":"74","author":"Funahashi","year":"2014","journal-title":"Prostate"},{"key":"2023012309264700600_bib21","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.mad.2004.09.023","article-title":"Profiling molecular targets of TGF-beta1 in prostate fibroblast-to-myofibroblast transdifferentiation","volume":"126","author":"Untergasser","year":"2005","journal-title":"Mech Ageing Dev"},{"key":"2023012309264700600_bib22","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s11934-008-0048-6","article-title":"Growth factors in benign prostatic hyperplasia: basic science implications","volume":"9","author":"Lucia","year":"2008","journal-title":"Curr Urol Rep"},{"key":"2023012309264700600_bib23","first-page":"1607","article-title":"Profibrotic role of myostatin in Peyronie's disease","volume":"5","author":"Cantini","year":"2008","journal-title":"J\u00a0Sex Med"},{"key":"2023012309264700600_bib24","first-page":"1391","article-title":"Peyronie's disease is associated with an increase in transforming growth factor-beta protein expression","volume":"158","author":"El-Sakka","year":"1997","journal-title":"J\u00a0Urol"},{"key":"2023012309264700600_bib25","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/1523-1747.ep12480289","article-title":"Activation of collagen gene expression in keloids: co-localization of type I and VI collagen and transforming growth factor-beta 1 mRNA","volume":"97","author":"Peltonen","year":"1991","journal-title":"J\u00a0Invest Dermatol"},{"key":"2023012309264700600_bib26","first-page":"95","article-title":"Prevalence, psychological impact, and risk factors of erectile dysfunction in patients with Peyronie's disease: a retrospective analysis of 309 cases","volume":"8","author":"Paulis","year":"2016","journal-title":"Res Rep Urol"},{"key":"2023012309264700600_bib27","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.urology.2004.04.006","article-title":"Comparison of gene expression profiles between Peyronie's disease and Dupuytren's contracture","volume":"64","author":"Qian","year":"2004","journal-title":"Urology"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609518309433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609518309433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/15\/6\/894\/48587344\/jsm_15_6_894.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/15\/6\/894\/48587344\/jsm_15_6_894.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T09:49:16Z","timestamp":1674467356000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/15\/6\/894\/6980286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,1]]},"references-count":27,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,6,1]]},"published-print":{"date-parts":[[2018,6,1]]}},"URL":"https:\/\/doi.org\/10.1016\/j.jsxm.2018.04.640","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2018,6]]},"published":{"date-parts":[[2018,6,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased Risk of Incident Disease in Men with Peyronie\u2019s Disease: Analysis of U.S. Claims Data","name":"articletitle","label":"Article Title"},{"value":"The Journal of Sexual Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsxm.2018.04.640","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Society for Sexual Medicine. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}